Production (Stage)
Ekso Bionics Holdings, Inc.
EKSO
$0.2798
$0.00120.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.20% | 25.45% | 26.59% | 22.84% | 4.11% |
| Total Depreciation and Amortization | -6.51% | -5.30% | 7.74% | 30.94% | 57.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.56% | 18.33% | -22.27% | 27.21% | 47.01% |
| Change in Net Operating Assets | 15.07% | -333.10% | 14.71% | -1,202.14% | 59.98% |
| Cash from Operations | 26.19% | 18.32% | 29.17% | 17.06% | 23.07% |
| Capital Expenditure | 68.29% | 76.43% | 64.67% | 76.63% | 47.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 68.29% | 76.43% | 98.85% | 98.71% | 97.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -99.68% | -299.36% | -- | -- | -- |
| Issuance of Common Stock | 92.03% | 1,264.75% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 90.79% | 2,132.47% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 96.30% | -29.17% | -205.26% | -216.67% | -485.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.04% | 81.96% | 91.45% | 60.11% | 62.42% |